Intent to Sole Source - X10 VIALS of Floxuridine 500MG vials

This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Cardinal Health dba Specialty Pharmaceutical Services (JND Therapeutics). Acquisition Description: The purpose of this acquisition is to purchase X10 VIALS of Floxuridine 500MG vials for injections for patient care. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-006059) by 12:00 PM eastern standard time on 06/03/2026 to: [email protected]. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.